Search

everythinglearnresearchcommunity

for

Search:↓

Microneedling improves hair growth in androgenetic alopecia when combined with minoxidil.

Low iron and vitamin D levels are linked to hair loss in women.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Mesotherapy shows promise for cellulite and facial rejuvenation but has mixed results for body sculpting and hair loss, with more research needed for safety and effectiveness.

Smoking is linked to more hair loss and premature graying compared to nonsmokers.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Topical cetirizine helps treat male hair loss.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.

People with AB blood type may be more likely to get melasma.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Smoking may worsen hair loss, but more research is needed.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Some cases of tinea capitis, a fungal scalp infection, can look like scarring hair loss due to the body's immune response and the fungus itself.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Athletes need effective management of skin disorders for their performance and well-being.

Hair loss in men treated best with early medication or transplant, new treatments researched.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Hair loss affects women's self-esteem; treatments like minoxidil can help.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.